Graphene Investments SAS Reduces Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Graphene Investments SAS cut its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 14.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,100 shares of the company's stock after selling 1,400 shares during the period. HCA Healthcare makes up about 2.0% of Graphene Investments SAS's portfolio, making the stock its 24th biggest holding. Graphene Investments SAS's holdings in HCA Healthcare were worth $2,799,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently modified their holdings of HCA. Congress Wealth Management LLC DE boosted its holdings in shares of HCA Healthcare by 3.4% in the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after purchasing an additional 34 shares in the last quarter. Evergreen Private Wealth LLC grew its position in HCA Healthcare by 0.3% in the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock valued at $3,838,000 after acquiring an additional 35 shares during the last quarter. Perigon Wealth Management LLC boosted its stake in shares of HCA Healthcare by 2.3% in the 1st quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company's stock valued at $621,000 after purchasing an additional 40 shares in the last quarter. Whittier Trust Co. increased its position in HCA Healthcare by 3.6% during the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock worth $359,000 after purchasing an additional 41 shares in the last quarter. Finally, Barden Capital Management Inc. boosted its position in HCA Healthcare by 1.4% in the first quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock valued at $1,009,000 after buying an additional 41 shares in the last quarter. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Up 0.4%

HCA stock traded up $1.34 during midday trading on Friday, reaching $379.00. 1,554,834 shares of the company's stock traded hands, compared to its average volume of 1,476,066. The company has a market cap of $91.18 billion, a price-to-earnings ratio of 16.85, a P/E/G ratio of 1.29 and a beta of 1.49. The firm's fifty day moving average price is $365.66 and its 200-day moving average price is $336.33. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping the consensus estimate of $5.75 by $0.70. The firm had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The company's quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the business posted $5.36 earnings per share. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.76%. The ex-dividend date is Monday, June 16th. HCA Healthcare's payout ratio is 12.81%.

Analyst Upgrades and Downgrades

HCA has been the topic of several recent research reports. Royal Bank Of Canada reissued an "outperform" rating and set a $404.00 price objective (up previously from $376.00) on shares of HCA Healthcare in a report on Monday. Guggenheim assumed coverage on HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating for the company. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Monday, April 28th. Morgan Stanley set a $410.00 price target on HCA Healthcare and gave the company an "equal weight" rating in a research note on Monday, June 9th. Finally, Barclays set a $416.00 target price on shares of HCA Healthcare and gave the stock an "overweight" rating in a research note on Monday, June 2nd. Seven analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $394.33.

Insider Transactions at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer now owns 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.30% of the company's stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.